Allogeneic HCT Outcomes with Carbapenem-Resistant Infections, 2015-2024

A retrospective analysis of 171 adult allogeneic hematopoietic cell transplant recipients between 2015 and 2024, comparing outcomes for patients with and without peri-transplant carbapenem-resistant organism infections. The dataset includes 43 cases and 128 propensity score-matched controls, with a median follow-up of 27 months. It was authored by Abeer Yaseen and shared on figshare under a CC-BY-4.0 license.

Use Cases

• Predicting one-year overall survival based on infection status and patient characteristics mentioned in the description.
• Analyzing risk factors for non-relapse mortality in transplant recipients based on clinical variables like ICU admission rates.
• Training models to identify patients at high risk for carbapenem-resistant infections using demographic and transplant procedure data.
• Studying the temporal trend of carbapenem-resistant infections in transplant centers based on the reported increase in the last three years.

Strengths

• 171 patient records with a defined study period from 2015 to 2024.
• Propensity score matching was performed on 6 key clinical variables to create comparable case and control groups.
• Multivariate analysis results, including hazard ratios for overall survival, are likely included.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.
• The dataset is small in scale at 100.9 KB, indicating limited scope.

Provenance

Source

figshare

Collection Method

Retrospective analysis of patient records.

Time Range

2015 to 2024

Freshness

Last updated 2026-05-15 05:31:06; freshness should be verified.